Health

NEWYou can now listen to Fox News articles! A lack of socializing may be a major risk factor for neurological disorders in older adults.New research from the University of New South Wales (UNSW) in Sydney, Australia, has considered how "social frailty" can be a predictor of dementia.The study, published in The Journals of Gerontology, looked at data from 851 people over the age of 70 in Sydney’s suburbs who did not have dementia at the time.ALZHEIMER'S RISK DECLINES SHARPLY WITH ONE DAILY LIFESTYLE CHANGE, RESEARCHERS SAYThe researchers evaluated social frailty using measures of social support, frequency of social interactions, sense of purpose, engagement in community or volunteer activities, and the individual's perceived social roles and connectedness, according to a press release...

NEWYou can now listen to Fox News articles! The World Health Organization (WHO) has announced its official guidance on the use of GLP-1 drugs for treating obesity.GLP-1 drugs are medications that mimic the natural hormone glucagon-like peptide-1 (GLP-1), which are most commonly used for type 2 diabetes and medical weight loss.The first guideline, released on Dec. 1, aims to address the "growing global health challenge of obesity," WHO wrote in a press release.WEIGHT LOSS DRUGS COULD ADD YEARS TO AMERICANS' LIVES, RESEARCHERS PROJECTObesity affects more than one billion people globally and was associated with 3.7 million deaths. The number of people with obesity is expected to double by 2030.While GLP-1 medications were added to the WHO’s Essential Medicines List for managing type 2 d...

NEWYou can now listen to Fox News articles! The shingles vaccine could slow the progress of dementia, according to a new study from Stanford.These findings follow previous research that found older adults who received the vaccine were 20% less likely to develop dementia over the next seven years compared to those who didn't get the shot."For the first time, we now have evidence that likely shows a cause-and-effect relationship between shingles vaccination and dementia prevention and treatment," Pascal Geldsetzer, M.D., Ph.D., assistant professor of medicine and senior author of the new study, told Fox News Digital.LISTENING TO MUSIC AFTER 70 MAY CUT DEMENTIA RISK BY NEARLY 40%, NEW STUDY SUGGESTSA team of scientists used public health data in Wales, where, for several years, eligibil...

Big leaps in science have made a once-impossible, much-debated question come to life: Would you design your unborn child?Kian Sadeghi, the 25-year-old founder and CEO at Nucleus Genomics, believes every parent has a right to do just that, selecting qualities they desire – from height to weight to intelligence. He calls it "genetic optimization," and it's part of a Silicon Valley push to breed "super-babies."Sadeghi dropped out of the University of Pennsylvania and started the company in 2021, inspired by a cousin who died of a rare genetic illness. Backed by investors and prominent tech entrepreneurs like Peter Thiel and Alexis Ohanian, Sadeghi says his company has already helped thousands of families."It's the parents' right to know""We give you the full range of insights there is...

NEWYou can now listen to Fox News articles! Eating a daily serving of peanuts may help older adults improve blood flow to their brains and boost memory, according to new research.In a study published in Clinical Nutrition, scientists at the NUTRIM Institute at Maastricht University Medical Center in the Netherlands set out to test whether this simple, inexpensive food could make a measurable difference in people's brains as they age.The team recruited 31 healthy older adults between the ages of 60 and 75. In one period of the study, participants ate 60 grams of unsalted, skin-roasted peanuts every day for 16 weeks. In another stage, they avoided peanuts entirely, according to a press release.YOUR BRAIN DOESN’T AGE THE WAY YOU THINK — NEUROSCIENTISTS REVEAL 5 STAGES OVER ONE LIFETIMET...

How to avoid holiday stress - CBS News ...

NEWYou can now listen to Fox News articles! On the heels of comedian Dave Coulier’s announcement of his tongue cancer diagnosis, experts are sharing what to know about the disease.Coulier, 66, announced in a Tuesday interview that he has been diagnosed with early-stage P16 carcinoma, or oropharyngeal tongue cancer. "Oropharyngeal" refers to cancer that begins at the base of the tongue. The "P16" indicates that it is associated with HPV (human papillomavirus).JAMES VAN DER BEEK IS IN 'HEALING PHASE' OF CANCER BATTLEThe news comes just months after the "Full House" star announced his battle with an aggressive form of non-Hodgkin Lymphoma. The tongue cancer is "totally unrelated" to that initial cancer, he told "Today" in the interview."I went in for a PET scan, just a routine check-up,...

NEWYou can now listen to Fox News articles! The West Virginia Board of Education reinstated its school vaccination policy after the state Supreme Court paused a lower court's ruling that allowed parents to cite religious beliefs to opt out of vaccines needed for children to attend school.The state Supreme Court issued a stay on Tuesday following last week's ruling by Raleigh County Circuit Judge Michael Froble in a class-action lawsuit. Froble said in his injunction that children whose parents refused the state’s vaccination requirement on religious grounds would be allowed to attend school and participate in extracurricular sports.Froble's ruling was blocked pending resolution of appeals in the case.The board said in a statement that it "is reinstating its directive to county boards...

San Francisco sues ultra-processed food makers - CBS News ...

NEWYou can now listen to Fox News articles! The World Health Organization (WHO) has announced its official guidance on the use of GLP-1 drugs for treating obesity.GLP-1 drugs are medications that mimic the natural hormone glucagon-like peptide-1 (GLP-1), which are most commonly used for type 2 diabetes and medical weight loss.The first guideline, released on Dec. 1, aims to address the "growing global health challenge of obesity," WHO wrote in a press release.WEIGHT LOSS DRUGS COULD ADD YEARS TO AMERICANS' LIVES, RESEARCHERS PROJECTObesity affects more than one billion people globally and was associated with 3.7 million deaths. The number of people with obesity is expected to double by 2030.While GLP-1 medications were added to the WHO’s Essential Medicines List for managing type 2 d...